460
Views
17
CrossRef citations to date
0
Altmetric
Research Articles

Liposomes with pH responsive ‘on and off’ switches for targeted and intracellular delivery of antibiotics

, , , , , , , , & ORCID Icon show all
Pages 45-63 | Received 18 Jun 2019, Accepted 16 Oct 2019, Published online: 19 Nov 2019

References

  • Abed, N., and Couvreur, P., 2014. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. International journal of antimicrobial agents, 43(6), 485–496.
  • Abed, N., et al., 2015. An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance. Scientific reports, 5, 13500.
  • Abraham, M.J., et al., 2015. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1, 19–25.
  • Abu-Humaidan, A.H., et al., 2018. Persistent intracellular Staphylococcus aureus in keratinocytes lead to activation of the complement system with subsequent reduction in the intracellular bacterial load. Frontiers in immunology, 9, 396.
  • Aminov, R.I., 2010. A brief history of the antibiotic era: lessons learned and challenges for the future. Frontiers in microbiology, 1, 134.
  • Anabousi, S., et al., 2005. Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy. European journal of pharmaceutics and biopharmaceutics, 60(2), 295–303.
  • Appelbaum, P.C., 2007. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). International journal of antimicrobial agents, 30(5), 398–408.
  • Austin, R.P., Davis, A.M., and Manners, C.N., 1995. Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles. Journal of pharmaceutical sciences, 84(10), 1180–1183.
  • Bixon, M., and Lifson, S., 1967. Potential functions and conformations in cycloalkanes. Tetrahedron, 23(2), 769–784.
  • Blanco, E., Shen, H., and Ferrari, M., 2015. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature biotechnology, 33(9), 941.
  • Braga, C., and Travis, K.P., 2005. A configurational temperature Nosé-Hoover thermostat. Journal of chemical physics, 123(13), 134101.
  • Briuglia, M.-L., et al., 2015. Influence of cholesterol on liposome stability and on in vitro drug release. Drug delivery and translational research, 5(3), 231–242.
  • Bruen, D., et al., 2017. Glucose sensing for diabetes monitoring: recent developments. Sensors, 17(8), 1866.
  • Bussi, G., Donadio, D., and Parrinello, M., 2007. Canonical sampling through velocity rescaling. Journal of chemical physics, 126(1), 014101.
  • Cao, X., et al., 2010. Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. Journal of materials science: materials in medicine, 21(10), 2861–2868.
  • Carryn, S., et al., 2002. Comparative Intracellular (THP-1 Macrophage) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrobial agents and chemotherapy, 46(7), 2095–2103.
  • Chaumeil, M.M., et al., 2012. pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. Journal of cerebral blood flow & metabolism, 32(5), 771–779.
  • Chen, L., et al., 2015. Synthesis and characterization of pH-responsive and fluorescent poly (amidoamine) dendrimer-grafted cellulose nanocrystals. Journal of colloid and interface science, 450, 101–108.
  • Chidambaram, M., Manavalan, R., and Kathiresan, K., 2011. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. Journal of pharmacy & pharmaceutical sciences, 14(1), 67–77.
  • Coates, A., et al., 2002. The future challenges facing the development of new antimicrobial drugs. Nature reviews drug discovery, 1(11), 895–910.
  • Cordeiro, C., et al., 2000. Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model. Antimicrobial agents and chemotherapy, 44(3), 533–539.
  • Costanzo, M., et al., 2016. Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery. European journal of histochemistry, 60(2), 2640–2640.
  • Cousins, K.R., 2011. Computer review of ChemDraw Ultra 12.0. Journal of the American chemical society, 133(21), 8388.
  • Cuendet, M.A., and Van Gunsteren, W.F., 2007. On the calculation of velocity-dependent properties in molecular dynamics simulations using the leapfrog integration algorithm. The journal of chemical physics, 127(18), 184102.
  • Cui, L., et al., 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrobial agents and chemotherapy, 44(9), 2276–2285.
  • Darden, T., York, D., and Pedersen, L., 1993. Particle mesh Ewald: an N log (N) method for Ewald sums in large systems. Journal of chemical physics, 98(12), 10089–10092.
  • Dathe, M., and Wieprecht, T., 1999. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochimica et Biophysica Acta (Bba) - Biomembranes, 1462(1–2), 71–87.
  • Dong, D., et al., 2015. Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa biofilm. PLoS One, 10(6), e0131806.
  • D'souza, S.S., and Deluca, P.P., 2006. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharmaceutical research, 23, 460–474.
  • Engel, M., et al., 2018. Bacterial inactivation by a carbon nanotube-iron oxide nanocomposite: a mechanistic study using E. coli mutants. Environmental science: nano, 5(2), 372–380.
  • Fittipaldi, M., Nocker, A., and Codony, F., 2012. Progress in understanding preferential detection of live cells using viability dyes in combination with DNA amplification. Journal of microbiological methods, 91(2), 276–289.
  • Friedrich, C.L., et al., 2001. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against Gram positive bacteria. Journal of biological chemistry, 276(26), 24015–24022.
  • Gao, W., et al., 2014. Nanoparticle approaches against bacterial infections. Wiley interdisciplinary reviews: nanomedicine and nanobiotechnology, 6(6), 532–547.
  • Garcia, C.B., Shi, D., and Webster, T.J., 2017. Tat-functionalized liposomes for the treatment of meningitis: an in vitro study. International journal of nanomedicine, 12, 3009.
  • Gordon, R.J., and Lowy, F.D., 2008. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clinical infectious diseases, 46(S5), S350–S59.
  • Hackam, D.J., et al., 1997. Regulation of Phagosomal Acidification differential targeting of Na+/H + exchangers, Na+/K+-ATPases, and vacuolar -type H+-ATPases. Journal of biological chemistry, 272(47), 29810–29820.
  • Hamid, R., et al., 2004. Comparison of alamar blue and MTT assays for high through-put screening. Toxicology in vitro, 18(5), 703–710.
  • Hiramatsu, K., 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. The lancet infectious diseases, 1(3), 147–155.
  • Horev, B., et al., 2015. pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. ACS nano, 9(3), 2390–2404.
  • Huang, C.-M., et al., 2011. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials, 32(1), 214–221.
  • Huang, J., et al., 2017. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nature Methods, 14(1), 71.
  • Ingram, P.R., et al., 2008. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. Journal of antimicrobial chemotherapy, 62(1), 168–171.
  • Institute CaLS 2012. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition. In: Institute CaLS (ed.). Pennsylvania 19087, USA: CLSI.
  • Iyisan, B., et al., 2016. Multifunctional and dual-responsive polymersomes as robust nanocontainers: design, formation by sequential post-conjugations, and pH-controlled drug release. Chemistry of materials, 28(5), 1513–1525.
  • Jadhav, M., et al., 2018. Novel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic delivery. Chemistry and physics of lipids, 212, 12–25.
  • Jespersen, H., et al., 2012. Lipids, curvature stress, and the action of lipid prodrugs: free fatty acids and lysolipid enhancement of drug transport across liposomal membranes. Biochimie, 94(1), 2–10.
  • Jorgensen, J.H., and Turnidge, J.D., 2015. Susceptibility test methods: dilution and disk diffusion methods. In: Jorgensen J, et al., ed. Manual of clinical microbiology, 11th Ed. Washington, DC: American Society of Microbiology Press, 1253–1273.
  • Kahl, B.C., Becker, K., and Löffler, B., 2016. Clinical significance and pathogenesis of staphylococcal small colony variants in persistent infections. Clinical microbiology reviews, 29(2), 401–427.
  • Kalhapure, R.S., et al., 2017a. pH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for controlled and targeted delivery of vancomycin. Colloids and surfaces b: biointerfaces, 158, 650–657.
  • Kalhapure, R.S., et al., 2017b. Enhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipid. Nanomedicine, 13, 2067–2077.
  • Kalhapure, R.S., et al., 2015. Nanoengineered drug delivery systems for enhancing antibiotic therapy. Journal of pharmaceutical sciences, 104(3), 872–905.
  • Kanamala, M., et al., 2016. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials, 85, 152–167.
  • Karami, Z., et al., 2016. Naproxen conjugated mPEG–PCL micelles for dual triggered drug delivery. Materials science and engineering: C, 61, 665–673.
  • Kugelberg, E., et al., 2005. Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes. Antimicrobial agents and chemotherapy, 49(8), 3435–3441.
  • Laxminarayan, R., et al., 2013. Antibiotic resistance—the need for global solutions. The lancet infectious diseases, 13(12), 1057–1098.
  • Lee, Y., and Thompson, D., 2017. Stimuli‐responsive liposomes for drug delivery. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 9
  • Liang, J., et al., 2014. pH Responsive micelle self-assembled from a new amphiphilic peptide as anti-tumor drug carrier. Colloids and surfaces B: biointerfaces, 114, 398–403.
  • Liu, J., et al., 2014. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnology advances, 32(4), 693–710.
  • Liu, J., et al., 2015. Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: characterization and evaluation. Asian journal of pharmaceutical sciences, 10, 212–222.
  • Loftsson, T., et al., 2016. Fatty acids from marine lipids: biological activity, formulation and stability. Journal of drug delivery science and technology, 34, 71–75.
  • Lowy, F.D., 1998. Staphylococcus aureus infections. New England journal of medicine, 339(8), 520–532.
  • Macgowan, A., and Macnaughton, E., 2017. Antibiotic resistance. Medicine, 45(10), 622–628.
  • Malani, A., et al., 2007. Extending the cure: policy responses to the growing threat of antibiotic resistance. Earthscan, 25. Available from: https://www.idsociety.org/globalassets/idsa/policy–advocacy/current_topics_and_issues/antimicrobial_resistance/strengthening_us_efforts/related-resources-and-websites/extending-the-cure-policy-responses-to-the-growing-threat-of-ar.pdf [Accessed 04 November 2019].
  • Marcus, Y., and Hefter, G., 2006. Ion pairing. Chemical reviews, 106(11), 4585–4621.
  • Mark, P., and Nilsson, L., 2001. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The journal of physical chemistry A, 105(43), 9954–9960.
  • Martinez, L.R., et al., 2009. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. Journal of investigative dermatology, 129(10), 2463–2469.
  • Maya, S., et al., 2012. Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. International journal of biological macromolecules, 51(4), 392–399.
  • Melcr, J., 2016a. POPC lipid membrane, 303K, Charmm36 force field, simulation files and 200 ns trajectory for Gromacs MD simulation engine v5.1.2. 2018.
  • Melcr, J., 2016b. POPC lipid membrane, 303K, Charmm36 force field, simulation files and 200 ns trajectory for Gromacs MD simulation engine v5.1.2. Zenodo.
  • Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods, 65(1–2), 55–63.
  • Mukherjee, S., et al., 2017. Accelerated molecular dynamics simulation analysis of MSI-594 in a lipid bilayer. Physical chemistry chemical physics, 19(29), 19289–19299.
  • Muppidi, K., et al., 2012. Development and stability studies of novel liposomal vancomycin formulations. 2012.
  • Nam, J., et al., 2009. pH-induced aggregation of gold nanoparticles for photothermal cancer therapy. Journal of the American chemical society, 131(38), 13639–13645.
  • Nicolosi, D., et al., 2015. Nanotechnology approaches for antibacterial drug delivery: preparation and microbiological evaluation of fusogenic liposomes carrying fusidic acid. International journal of antimicrobial agents, 45(6), 622–626.
  • Nicolosi, D., et al., 2010. Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. International journal of antimicrobial agents, 35(6), 553–558.
  • O’brien-Simpson, N.M., et al., 2016. A Rapid and Quantitative flow cytometry method for the analysis of membrane disruptive antimicrobial activity. PloS one, 11, e0151694.
  • Omolo, C.A., et al., 2018a. A hybrid of mPEG-b-PCL and G1-PEA dendrimer for enhancing delivery of antibiotics. Journal of controlled release, 290, 112–128.
  • Omolo, C.A., et al., 2018b. Formulation and molecular dynamics simulations of a fusidic acid nanosuspension for simultaneously enhancing solubility and antibacterial activity. Molecular pharmaceutics, 15(8), 3512–3526.
  • Omolo, C.A., et al., 2017. Pegylated oleic acid: a promising amphiphilic polymer for nano-antibiotic delivery. European journal of pharmaceutics and biopharmaceutics, 112, 96–108.
  • Parrinello, M., and Rahman, A., 1981. Polymorphic transitions in single crystals: a new molecular dynamics method. Journal of applied physics, 52(12), 7182–7190.
  • Paternostre, M., and Artzner, F., 2017. pH responsive peptide self-assemblies: a mechanism as old as viruses. Biophysical journal, 112(3), 359a–360a.
  • Pattni, B.S., Chupin, V.V., and Torchilin, V.P., 2015. New developments in liposomal drug delivery. Chemical reviews, 115(19), 10938–10966.
  • Pinto-Alphandary, H., Andremont, A., and Couvreur, P., 2000. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. International journal of antimicrobial agents, 13(3), 155–168.
  • Radovic-Moreno, A.F., et al., 2012. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS nano, 6(5), 4279–4287.
  • Rane, V., 2016. pH sensitive liposomes for targeted delivery of antibiotics to localized internal bacterial infection sites. New Brunswick: Rutgers The State University of New Jersey.
  • Renggli, S., et al., 2013. Role of autofluorescence in flow cytometric analysis of Escherichia coli treated with bactericidal antibiotics. Journal of bacteriology, 195(18), 4067–4073.
  • Riss, T. L., et al., 2004. Assay Guidance Manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences.
  • Samad, A., Sultana, Y., and Aqil, M., 2007. Liposomal drug delivery systems: an update review. Current drug delivery, 4(4), 297–305.
  • Sandberg, A., et al., 2009. Intracellular activity of antibiotics against Staphylococcus aureus in a mouse Peritonitis model. Antimicrobial agents and chemotherapy, 53(5), 1874–1883.
  • Santos, R.S., et al., 2017. Intracellular delivery of oligonucleotides in Helicobacter pylori by fusogenic liposomes in the presence of gastric mucus. Biomaterials, 138, 1–12.
  • Sémiramoth, N., et al., 2012. Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. ACS Nano, 6(5), 3820–3831.
  • Seral, C., Van Bambeke, F., and Tulkens, P.M., 2003. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) Activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrobial agents and chemotherapy, 47(7), 2283–2292.
  • Sikwal, D.R., et al., 2017. Non-ionic self-assembling amphiphilic polyester dendrimers as new drug delivery excipients. RSC advances, 7(23), 14233–14246.
  • Sommer, M.O.A., et al., 2017. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nature reviews microbiology, 15(11), 689.
  • Sudimack, J.J., et al., 2002. A novel pH-sensitive liposome formulation containing oleyl alcohol. Biochimica et Biophysica Acta (Bba) - Biomembranes, 1564(1), 31–37.
  • Surewaard, B.G.J., et al., 2016. Identification and treatment of the Staphylococcus aureus reservoir in vivo. The journal of experimental medicine, 213(7), 1141–1151.
  • Torchilin, V.P., 2014. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature reviews drug discovery, 13(11), 813.
  • Vanommeslaeghe, K., et al., 2010. CHARMM general force field: a force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields. Journal of computational chemistry, 31, 671–690.
  • Verma, S., et al., 2014. Oleic acid vesicles: a new approach for topical delivery of antifungal agent. Artificial cells, nanomedicine, and biotechnology, 42(2), 95–101.
  • Versluis, F., et al., 2013. In situ modification of plain liposomes with lipidated coiled coil forming peptides induces membrane fusion. Journal of the American chemical society, 135(21), 8057–8062.
  • Wang, H., et al., 2016. Stimuli-responsive dendrimers in drug delivery. Biomaterials science, 4(3), 375–390.
  • Wang, L., et al., 2015. Acid-disintegratable polymersomes of ph-responsive amphiphilic diblock copolymers for intracellular drug delivery. Macromolecules, 48(19), 7262–7272.
  • Wong, J.P., et al., 2003. Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection. Journal of controlled release, 92(3), 265–273.
  • Woraphatphadung, T., et al., 2016. pH-Responsive polymeric micelles based on amphiphilic chitosan derivatives: Effect of hydrophobic cores on oral meloxicam delivery. International journal of pharmaceutics, 497(1–2), 150–160.
  • Xing, H., et al., 2016. Multimodal detection of a small molecule target using stimuli-responsive liposome triggered by aptamer–enzyme conjugate. Analytical chemistry, 88(3), 1506–1510.
  • Yang, D., et al., 2009. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials, 30(30), 6035–6040.
  • Yang, R., et al., 2018. Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection. Biochimie, 146, 139–147.
  • Yu, Q., Wu, Z., and Chen, H., 2015. Dual-function antibacterial surfaces for biomedical applications. Acta Biomaterialia, 16, 1–13.
  • Zhang, Y., et al., 2010. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. The AAPS journal, 12(3), 263–271.
  • Zhao, Y., et al., 2015. pH-responsive polymeric micelles based on poly (2-ethyl-2-oxazoline)-poly (D, L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Acta Biomaterialia, 17, 182–192.
  • Zhu, D., et al., 2017. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma. Acta Biomaterialia, 58, 399–412.
  • Zhu, Y.J., and Chen, F., 2015. pH‐responsive drug‐delivery systems. Chemistry - an Asian journal, 10(2), 284–305.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.